Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Research » Trials

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Exenatide Once Weekly DURATION-5 Study Results Announced
Posted: Sunday, December 20, 2009
Eli Lilly and Company, and Amylin announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with Type 2 diabetes.

Update on Generex Oral-lyn
Posted: Sunday, December 13, 2009
An independent review of clinical trials of Generex Oral-lyn(TM) shows that the oral insulin spray has a faster onset of action and shorter duration of action than insulin delivered subcutaneously.

BARI 2D Study Favors Medication over Bypass Surgery for Diabetes Patients
Posted: Monday, November 30, 2009
Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark Hlatky, MD.

Moving Forward with Oral Insulin -- the Holy Grail of Diabetes Therapy
Posted: Monday, November 23, 2009
Danish drugmaker Novo, the world's biggest insulin maker, stated that it is making progress in developing a tablet form of the drug -- a holy grail of diabetes therapy.

Newer, More Effective Laser Treatment for Diabetic Macular Edema
Posted: Monday, November 09, 2009
A sub-threshold micropulse diode laser (MPDL) is as effective as a conventional green laser (CGL) for the photocoagulation of diabetes-related macular edema, according to the results of a controlled trial.

Research Points to New Way to Treat Type 2 Diabetes: Insulin First
Posted: Wednesday, October 28, 2009
Three years into a six-year study and researchers have reported that the standard treatment for patients with Type 2 diabetes may have to be turned on its head.

Study Finds How Substance in Grapes Can Improve Glucose Control
Posted: Wednesday, October 28, 2009
A naturally produced molecule called resveratrol, found in the skin of red grapes, has been shown to lower insulin levels in mice when injected directly into the brain, even when the animals ate a high-fat diet.

Positive Results for a New First in Class Diabetes Drug
Posted: Wednesday, October 21, 2009
MBX-2982 could be a potential first-in-class treatment for Type 2 diabetes that may offer improved glucose homeostasis over existing therapies.

EASD: Lidocaine Patch Beats Pregabalin for Diabetic Nerve Pain
Posted: Wednesday, October 07, 2009
A dermal patch containing 5% lidocaine (Lidoderm) proved as effective as pregabalin (Lyrica) in relieving neuropathic pain in diabetic patients with dramatically fewer side effects.

EASD: AFRESA® Phase 3 Data Show Sustained Glycemic Control, Normal Lung Function in Patients over Four Years of Treatment
Posted: Wednesday, October 07, 2009
Long-term study in adults with Type 2 diabetes presented at the 45th annual meeting of the European Association for the Study of Diabetes.

Page 10 of 23
 |<   <<   <  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  >   >>   >| 

 
 
 
 
 
Join us on Facebook
 
 
 

Send your unopened, unexpired diabetes testing supplies to:

Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement